MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Back
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)
Income Statement
Quarterly Income Statement for the quarter ending in 2026-07-31
source: myfinsight.com
CSBR Income Statement Sankey Diagram
Sankey diagram visualizing CSBR income statement for the period
Net income (loss)
attributable to company's...
-$426K
(2.29%↑ Y/Y)
Loss before
provision for income taxes
-$415K
(8.19%↑ Y/Y)
Provision for income taxes
$11K
(-21.43%↓ Y/Y)
Pharmacology Services
$14,156K
Translational Oncology
Solutions TOSLicense...
$893K
(187.14%↑ Y/Y)
Product And Service
Other
$183K
(-59.69%↓ Y/Y)
Loss from operations
-$409K
(22.39%↑ Y/Y)
Other income
(expense), net
-$6K
(-108.00%↓ Y/Y)
Oncology revenue
$15,232K
(8.84%↑ Y/Y)
Total costs and
operating expenses
$15,641K
(7.71%↑ Y/Y)
Cost of oncology
revenue
$7,534K
(-5.77%↓ Y/Y)
Sales and marketing
$3,090K
(66.58%↑ Y/Y)
General and
administrative
$2,673K
(4.01%↑ Y/Y)
Research and development
$2,344K
(12.58%↑ Y/Y)
Back